Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
9 papers
Recent·Most cited
T. Stuedemann, B. Schwarzova, T. Schneidewind, B. Geertz, C. von Bibra, M. Nehring, J. Roessinger, J. S. Wiegert, T. Eschenhagen, F. Weinberger
This study shows that transplanted cardiomyocytes can electrically couple to the host myocardium and stimulate the recipient heart, triggering ventricular arrhythmias.
Stem Cell Reports · Aug 1, 2024Peer-reviewedPharmacology & Toxicology
C. Schulz, M. Soenmez, J. Krause, E. Schwedhelm, P. Bangfen, D. Alihodzic, A. Hansen, T. Eschenhagen, T. Christ
This study shows that 1 μM retinoic acid is necessary and sufficient to induce a fully human-like atrial phenotype in hiPSC-CMs, overcoming methodological challenges in RA concentration control.
bioRxiv · Jan 3, 2023 · PreprintPharmacology & Toxicology
A. T. Zech, M. Prondzynski, S. R. Singh, N. Pietsch, E. Orthey, E. Alizoti, J. Busch, A. Madsen, C. S. Behrens, M. Meyer-Jens, G. Mearini, M. D. Lemoine, E. Kraemer, D. Mosqueira, S. Virdi, , L. Carrier
This study shows that an ACTN2 mutation leads to proteopathy in human iPSC-derived cardiomyocytes through protein aggregation and activation of proteolytic systems.
Cells · Sep 2, 2022Peer-reviewedCell Biology
C. von Bibra, A. Shibamiya, A. Baehr, B. Geertz, M. Koehne, T. Stuedemann, J. Starbatty, N. Hornaschewitz, E. Wolf, N. Klymiuk, M. Krane, C. Kupatt, B. Hiebl, T. Eschenhagen, F. Weinberger
This study shows that transplanting immature engineered heart tissue patches improves cardiomyocyte engraftment in a chronic injury guinea pig model.
bioRxiv · Jul 7, 2022 · PreprintPharmacology & Toxicology
T. Stuedemann, J. Roessinger, C. Manthey, B. Geertz, R. Srikantharajah, C. C. von Bibra, A. Shibamiya, M. Koehne, A. Wiehler, J. S. Wiegert, T. Eschenhagen, F. Weinberger
This study shows transplanted cardiomyocytes actively contribute to heart function recovery after injury using optogenetic control in a guinea pig model.
bioRxiv · Nov 23, 2021Pharmacology & Toxicology
N. M. Wickramasinghe, D. Sachs, B. Shewale, D. M. Gonzalez, P. Dhanan-Krishnan, D. Torre, E. LaMarca, S. Raimo, R. Dariolli, M. Serasinghe, J. Mayourian, R. Sebra, K. G. Beaumont, R. Iyengar, D. L. French, , N. C. Dubois
This study shows that activating PPARD signaling enhances metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.
bioRxiv · Jul 12, 2021 · PreprintCell Biology
C. von Bibra, A. Shibamiya, B. Geertz, E. Querdel, M. Koehne, T. Stuedemann, J. Starbatty, A. Hansen, B. Hiebl, T. Eschenhagen, F. Weinberger
This study transplants human engineered heart tissue (EHT) into chronically injured guinea pig hearts and finds limited functional improvement despite engraftment.
bioRxiv · Jun 28, 2021Pharmacology & Toxicology
D. Bojkova, J. Wagner, M. Shumliakivska, G. Aslan, U. Saleem, A. Hansen, G. Luxan, S. Guenther, M. D. Pham, J. Krishnan, P. Harter, U. Ermel, A. S. Frangakis, A. Zeiher, H. Milting, , S. Dimmeler
This study shows SARS-CoV-2 infects human cardiomyocytes, causing cytotoxicity and apoptosis, and confirms this in cardiac tissue models.
bioRxiv · Jun 1, 2020Cell Biology
L. Sala, B. J. van Meer, L. G. J. Tertoolen, J. Bakkers, M. Bellin, R. Davis, C. Denning, M. A. E. Dieben, T. Eschenhagen, E. Giacomelli, C. Grandela, A. Hansen, E. R. Holman, M. R. M. Jongbloed, S. M. Kamel, , F. L. Burton
MUSCLEMOTION quantifies cardiac contraction in vitro and in vivo, providing reliable pharmacological and disease phenotype data across multiple models.
bioRxiv · Jul 8, 2017Physiology